1055 related articles for article (PubMed ID: 31665092)
1. Biomarkers and clinical scores to identify patient populations at risk of delayed antibiotic administration or intensive care admission.
Gonzalez Del Castillo J; Wilson DC; Clemente-Callejo C; Román F; Bardés-Robles I; Jiménez I; Orviz E; Dastis-Arias M; Espinosa B; Tornero-Romero F; Giol-Amich J; González V; Llopis-Roca F;
Crit Care; 2019 Oct; 23(1):335. PubMed ID: 31665092
[TBL] [Abstract][Full Text] [Related]
2. The early identification of disease progression in patients with suspected infection presenting to the emergency department: a multi-centre derivation and validation study.
Saeed K; Wilson DC; Bloos F; Schuetz P; van der Does Y; Melander O; Hausfater P; Legramante JM; Claessens YE; Amin D; Rosenqvist M; White G; Mueller B; Limper M; Callejo CC; Brandi A; Macchi MA; Cortes N; Kutz A; Patka P; Yañez MC; Bernardini S; Beau N; Dryden M; van Gorp ECM; Minieri M; Chan L; Rood PPM; Del Castillo JG
Crit Care; 2019 Feb; 23(1):40. PubMed ID: 30736862
[TBL] [Abstract][Full Text] [Related]
3. The use of mid-regional proadrenomedullin to identify disease severity and treatment response to sepsis - a secondary analysis of a large randomised controlled trial.
Elke G; Bloos F; Wilson DC; Brunkhorst FM; Briegel J; Reinhart K; Loeffler M; Kluge S; Nierhaus A; Jaschinski U; Moerer O; Weyland A; Meybohm P;
Crit Care; 2018 Mar; 22(1):79. PubMed ID: 29562917
[TBL] [Abstract][Full Text] [Related]
4. Combination of the National Early Warning Score (NEWS) and inflammatory biomarkers for early risk stratification in emergency department patients: results of a multinational, observational study.
Eckart A; Hauser SI; Kutz A; Haubitz S; Hausfater P; Amin D; Amin A; Huber A; Mueller B; Schuetz P
BMJ Open; 2019 Jan; 9(1):e024636. PubMed ID: 30782737
[TBL] [Abstract][Full Text] [Related]
5. MR- proADM to detect specific types of organ failure in infection.
Andrés C; Andaluz-Ojeda D; Cicuendez R; Nogales L; Martín S; Martin-Fernandez M; Almansa R; Calvo D; Esteban-Velasco MC; Vaquero-Roncero LM; Ríos-Llorente A; Sanchez-Barrado E; Muñoz-Bellvís L; Aldecoa C; Bermejo-Martin JF
Eur J Clin Invest; 2020 Jun; 50(6):e13246. PubMed ID: 32307701
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of midregional pro-adrenomedullin as a marker of organ damage and predictor of mortality in patients with sepsis.
Bernal-Morell E; García-Villalba E; Vera MDC; Medina B; Martinez M; Callejo V; Valero S; Cinesi C; Piñera P; Alcaraz A; Marin I; Muñoz A; Cano A
J Infect; 2018 Mar; 76(3):249-257. PubMed ID: 29246637
[TBL] [Abstract][Full Text] [Related]
7. Procalcitonin and MR-Proadrenomedullin Combination with SOFA and qSOFA Scores for Sepsis Diagnosis and Prognosis: A Diagnostic Algorithm.
Spoto S; Cella E; de Cesaris M; Locorriere L; Mazzaroppi S; Nobile E; Lanotte AM; Pedicino L; Fogolari M; Costantino S; Dicuonzo G; Ciccozzi M; Angeletti S
Shock; 2018 Jul; 50(1):44-52. PubMed ID: 29023361
[TBL] [Abstract][Full Text] [Related]
8. Biomarker guided triage can reduce hospitalization rate in community acquired febrile urinary tract infection.
Stalenhoef JE; van Nieuwkoop C; Wilson DC; van der Starre WE; Delfos NM; Leyten EMS; Koster T; Ablij HC; Van't Wout JJW; van Dissel JT
J Infect; 2018 Jul; 77(1):18-24. PubMed ID: 29807091
[TBL] [Abstract][Full Text] [Related]
9. Procalcitonin, mid-regional proadrenomedullin and C-reactive protein in predicting treatment outcome in community-acquired febrile urinary tract infection.
Stalenhoef JE; van Nieuwkoop C; Wilson DC; van der Starre WE; van der Reijden TJK; Delfos NM; Leyten EMS; Koster T; Ablij HC; van 't Wout JJW; van Dissel JT
BMC Infect Dis; 2019 Feb; 19(1):161. PubMed ID: 30764769
[TBL] [Abstract][Full Text] [Related]
10. High levels of mid-regional proadrenomedullin in ARDS COVID-19 patients: the experience of a single, Italian Center.
Benedetti I; Spinelli D; Callegari T; Bonometti R; Molinaro E; Novara E; Cassinari M; Frino C; Guaschino R; Boverio R; Lauritano EC
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1743-1751. PubMed ID: 33629344
[TBL] [Abstract][Full Text] [Related]
11. Does mid-regional pro-adrenomedullin (MR-proADM) improve the sequential organ failure assessment-score (SOFA score) for mortality-prediction in patients with acute infections? Results of a prospective observational study.
Haag E; Gregoriano C; Molitor A; Kloter M; Kutz A; Mueller B; Schuetz P
Clin Chem Lab Med; 2021 May; 59(6):1165-1176. PubMed ID: 33554514
[TBL] [Abstract][Full Text] [Related]
12. Mid-regional pro-adrenomedullin and copeptin to predict short-term prognosis of COPD exacerbations: a multicenter prospective blinded study.
Dres M; Hausfater P; Foissac F; Bernard M; Joly LM; Sebbane M; Philippon AL; Gil-Jardiné C; Schmidt J; Maignan M; Treluyer JM; Roche N
Int J Chron Obstruct Pulmon Dis; 2017; 12():1047-1056. PubMed ID: 28408815
[TBL] [Abstract][Full Text] [Related]
13. Mid-Regional Pro-Adrenomedullin in Combination With Pediatric Early Warning Scores for Risk Stratification of Febrile Children Presenting to the Emergency Department: Secondary Analysis of a Nonprespecified United Kingdom Cohort Study.
Lenihan RAF; Ang J; Pallmann P; Romaine ST; Waldron CA; Thomas-Jones E; Miah N; Carrol ED
Pediatr Crit Care Med; 2022 Dec; 23(12):980-989. PubMed ID: 36239515
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic and prognostic role of procalcitonin (PCT) and MR-pro-Adrenomedullin (MR-proADM) in bacterial infections.
Angeletti S; Spoto S; Fogolari M; Cortigiani M; Fioravanti M; De Florio L; Curcio B; Cavalieri D; Costantino S; Dicuonzo G
APMIS; 2015 Sep; 123(9):740-8. PubMed ID: 26058482
[TBL] [Abstract][Full Text] [Related]
15. Mr-Proadm Elevation Upon Icu Admission Predicts the Outcome of Septic Patients and is Correlated with Upcoming Fluid Overload.
Charles PE; Péju E; Dantec A; Bruyère R; Meunier-Beillard N; Dargent A; Prin S; Wilson D; Quenot JP
Shock; 2017 Oct; 48(4):418-426. PubMed ID: 28414691
[TBL] [Abstract][Full Text] [Related]
16. Proadrenomedullin improves Risk of Early Admission to ICU score for predicting early severe community-acquired pneumonia.
Renaud B; Schuetz P; Claessens YE; Labarère J; Albrich W; Mueller B
Chest; 2012 Dec; 142(6):1447-1454. PubMed ID: 22661450
[TBL] [Abstract][Full Text] [Related]
17. Mid-regional proadrenomedullin: An early marker of response in critically ill patients with severe community-acquired pneumonia?
Pereira JM; Azevedo A; Basílio C; Sousa-Dias C; Mergulhão P; Paiva JA
Rev Port Pneumol (2006); 2016; 22(6):308-314. PubMed ID: 27160747
[TBL] [Abstract][Full Text] [Related]
18. Mid regional pro-adrenomedullin for the prediction of organ failure in infection. Results from a single centre study.
Viaggi B; Poole D; Tujjar O; Marchiani S; Ognibene A; Finazzi S
PLoS One; 2018; 13(8):e0201491. PubMed ID: 30102716
[TBL] [Abstract][Full Text] [Related]
19. Thirty and ninety days mortality predictive value of admission and in-hospital procalcitonin and mid-regional pro-adrenomedullin testing in patients with dyspnea. Results from the VERyfing DYspnea trial.
Travaglino F; Russo V; De Berardinis B; Numeroso F; Catania P; Cervellin G; Nigra SG; Geraci F; Bressan MA; Guerrini S; Cavazza M; Folli C; Monzani V; Battista S; Mengozzi G; Noto P; Carpinteri G; Semplicini A; Stella F; Ingrassia S; Moscatelli P; Giuntini P; Salerno G; Cardelli P; Di Somma S
Am J Emerg Med; 2014 Apr; 32(4):334-41. PubMed ID: 24559907
[TBL] [Abstract][Full Text] [Related]
20. MR-proADM as marker of endotheliitis predicts COVID-19 severity.
García de Guadiana-Romualdo L; Calvo Nieves MD; Rodríguez Mulero MD; Calcerrada Alises I; Hernández Olivo M; Trapiello Fernández W; González Morales M; Bolado Jiménez C; Albaladejo-Otón MD; Fernández Ovalle H; Conesa Hernández A; Azpeleta Manrique E; Consuegra-Sánchez L; Nogales Martín L; Conesa Zamora P; Andaluz-Ojeda D
Eur J Clin Invest; 2021 May; 51(5):e13511. PubMed ID: 33569769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
